Antibiotic Guidelines in ICU
Revised and reviewed 17 December 2015
OVERVIEW
- Antibiotic guidelines vary between ICUs
- This variation is based on local causes of infections, resistance patterns, availability and patient factors
- However, the principles of appropriate use of antibiotics are universal… as are the common errors!
PRINCIPLES OF APPROPRIATE USE OF ANTIBIOTICS
Adapted from Lipman:
- Take cultures before administering antibiotics
- Take two sets of cultures, not from a line
- Timing of blood cultures with fever is not critical
- Do not delay the administration of antibiotics
- Use empirical therapy first; narrow the spectrum later
- Ensure initial doses are sufficient – under-doing must be avoided
- use monotherapy where possible (reduces cost and toxicity).
- If the microbiology results suggest decreased susceptibility, consider whether the antibiotics working clinically. If there is direct bedside evidence that they are working, then continue them in spite of laboratory evidence. In vitro sensitivity does not always predict in vivo effect
- A shorter course (e.g. 7 days) is probably as good as a standard 2-week course in most cases
- Infectious diseases specialists should be consulted when managing serious infections
- Know antimicrobial pharmacokinetics and pharmacodynamics; consider tissue penetration and dose adjustment to correct for altered clearance
- Monitor antibiotic levels when available
- Limit “prophylactic” use to appropriate situations
- Consider non-infective causes of inflammation (sepsis mimics are surprisingly common)
- Adhere to infection control policies
- Have an antimicrobial stewardship program in the ICU
COMMON ERRORS IN ANTIBIOTIC USE
Adapted from Lipman:
- Delay in antibiotic administration in severe sepsis
- Antibiotics given before cultures taken
- Contaminated or insufficient blood culture collection
- Excessively long courses of antibiotics
- Erratic changes of antibiotics in non-resolving sepsis
- Inadequate doses
- Poor choice of empirical antibiotics, failing to account for resident flora
- Failure to predict toxicity or account for interactions
- Failure to consider tissue penetration of different antibiotics
- Inappropriate use of antibiotic polypharmacy or failure to de-escalate to monotherapy
FACTORS THAT DETERMINE INITIAL CHOICE OF ANTIBIOTICS
Table from Deranged Physiology — General principles and common errors of antimicrobial use:
1 | 2 |
---|---|
Factors | Discussion and examples |
DISEASE SPECIFICS | |
Travel history |
|
Occupational exposure |
|
Recreational exposure |
|
Recent antimicrobial use |
|
Empiric vs. definitive |
|
Urgency and timing |
|
Reliability of cultures |
|
HOST FACTORS | |
Clearance |
|
Age |
|
Genetic variation |
|
Pregnancy and lactation |
|
Immunocompetence |
|
Allergies |
|
ORGANISM FACTORS | |
Susceptibility |
|
Biology |
|
Source control |
|
Duration of therapy |
|
Assessment of response |
|
DRUG FACTORS | |
Cost |
|
Toxicity |
|
Bioavailability |
|
Site penetration |
|
Bactericidal vs bacteriostatic |
|
Synergistic combination |
|
EXAMPLE OF AN ICU ANTIBIOTIC GUIDELINE
General rules
- investigate first, start aggressively, and streamline quickly to reduce resistance
- ideally 3 sets of blood cultures first from fresh sites, 10 mL each
- empiric antibiotic choices based on syndromic approach
Pneumonia
- ceftraixone + azithromycin (community acquired)
- ceftriaxone + metronidazole (aspiration)
Abdominal focus
- ampicilin + gentamicin + metronidazole
Neurosurgical infection
- vancomycin 1g q6h + ceftazidime 2g q6h
- no need for routine prophylaxis if EVD inserted
Necrotizing fasciitis
- meropenem 1g q8h + benzylpenicilin 2.4g q4h + lincomycin 900mg q8h
- if GPC on biopsy = suspect group A streptococcus -> IvIg 1g/kg on day 1, 0.5 g/kg/d on days 2 and 3
Sepsis unknown source or VAP
- always cover prior resistant bacteria even if found much earlier (e.g. VRE if previously colonised)
- tazocin + gentamicin
if mild rash to penicillin then cefepime + gentamicin
if anaphylaxis/ DRESS/ Steven-Johnson to penicillin then vancomycin + aztreonam + gentamicin
use ciprofloxacin not gentamicin if eGFR <50, age >65y or recently on gentamicin - add vancomycin if:
hospitalised >7 days or recent admission past 3 months
prior MRSA
pre-existing longterm lines - teichoplanin if VRE colonised
- add fungal cover in severe sepsis using fluconazole if ECMO or yeast isolated
if already on fluconazole change to caspofungin
if already on posaconazole or voriconazle talk to ID!
When to stop antibiotics
- Day 2
vanc/ gent/ cipro/ flucon/ caspo
if patient improved and no MRSA, resistant GNBs or candida
streamline tazocin when sensitivities available
switch gentamicin to ciprofloxacin if 2nd agent still needed - Day 6
stop all antibiotics unless specific diagnosis requires longer – discuss with ID - Line sepsis
Staph aureus – change lines, perform TOE -> Rx for 14d if no endocarditis or low risk
Coag neg staph – change lines -> Rx 2-5 days
References and Links
LITFL
- CCC — Antimicrobial dosing and kill characteristics
- CCC — Antibiotic Dosing in Renal Replacement Therapy
- CCC — Antibiotic timing
- CCC — Unresolved sepsis
FOAM and web resources
- Deranged Physiology — General principles and common errors of antimicrobial use
Journal articles and textbooks
- Lipman, J. Principles of antibiotic use. Chapter 72 in Oh’s Intensive Care Manual
- Leekha S, Terrell CL, Edson RS. General principles of antimicrobial therapy. Mayo Clinic proceedings. 86(2):156-67. 2011. [pubmed] [free full text]
Critical Care
Compendium
Chris is an Intensivist and ECMO specialist at the Alfred ICU in Melbourne. He is also a Clinical Adjunct Associate Professor at Monash University. He is a co-founder of the Australia and New Zealand Clinician Educator Network (ANZCEN) and is the Lead for the ANZCEN Clinician Educator Incubator programme. He is on the Board of Directors for the Intensive Care Foundation and is a First Part Examiner for the College of Intensive Care Medicine. He is an internationally recognised Clinician Educator with a passion for helping clinicians learn and for improving the clinical performance of individuals and collectives.
After finishing his medical degree at the University of Auckland, he continued post-graduate training in New Zealand as well as Australia’s Northern Territory, Perth and Melbourne. He has completed fellowship training in both intensive care medicine and emergency medicine, as well as post-graduate training in biochemistry, clinical toxicology, clinical epidemiology, and health professional education.
He is actively involved in in using translational simulation to improve patient care and the design of processes and systems at Alfred Health. He coordinates the Alfred ICU’s education and simulation programmes and runs the unit’s education website, INTENSIVE. He created the ‘Critically Ill Airway’ course and teaches on numerous courses around the world. He is one of the founders of the FOAM movement (Free Open-Access Medical education) and is co-creator of litfl.com, the RAGE podcast, the Resuscitology course, and the SMACC conference.
His one great achievement is being the father of three amazing children.
On Twitter, he is @precordialthump.
| INTENSIVE | RAGE | Resuscitology | SMACC